PLA2G4A antibody (pSer505)
Quick Overview for PLA2G4A antibody (pSer505) (ABIN1387828)
Target
See all PLA2G4A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer505
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Rat,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic phosphopeptide derived from human CPLA2 around the phosphorylation site of Ser505 [PL(p-S)PL]
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
-
Alternative Name
- CPLA2
-
Background
-
Synonyms: Cytosolic phospholipase A2, cPLA2, Phospholipase A2 group IVA, PLA2G4A, CPLA2, PLA2G4, PA24A_HUMAN.
Background: Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. Together with its lysophospholipid activity, it is implicated in the initiation of the inflammatory response.
-
Gene ID
- 5321
-
UniProt
- P47712
-
Pathways
- Inositol Metabolic Process, G-protein mediated Events, VEGF Signaling
Target
-